Adhesives Research to Present Hydrophilic Adhesive Technologies
|
By LabMedica International staff writers Posted on 03 Aug 2016 |
|
Image: Hydrophilic technologies for microfluidic devices (Photo courtesy of Adhesives Research).
Adhesives Research (AR; Glen Rock, PA, USA), a leading developer and manufacturer of high-performance pressure-sensitive adhesives, tapes, specialty coatings, films, and laminates, will hold a presentation at AACC 2016 on the range of opportunities for hydrophilic adhesive technologies, which are expanding as demand for microfluidic biological tests increases. They will also be presenting a range of custom tailored products, from devices that detect infectious diseases to test kits that monitor diabetes and blood coagulation.
Hydrophilic adhesive technologies reduce the surface tension of fluids, such as water, urine, or blood to allow for rapid flow from the inlet area to a remote reagent site within in vitro diagnostic (IVD) and microfluidic devices. Available as pressure-sensitive adhesives (PSAs), heat-seals, and coatings, the technology is compatible with sensitive chemistries, demonstrates strong bonding to low-surface energy plastics, provides tailorable hydrophilic properties to regulate capillary fill time, and can be customized by modifying thickness, choice of substrate, and release liner.
“Hydrophilic technology continues to be used in a variety of medical devices, including blood glucose and blood coagulation point-of-care, in-house, and environmental test kits,” said Herb Hand, a senior scientist with over 24 years pioneering research on hydrophilic adhesives and coatings at AR, who will lead the discussion. “The future of hydrophilic tapes includes components in molecular diagnostic devices and devices for the discovery of infectious diseases.”
AR leverages core competencies in chemical synthesis formulation and coating technologies to provide a gamut of custom tailored products for diverse applications around the world in the construction, industrial, electronics, automotive, medical, and pharmaceutical industries. AR also operates manufacturing facilities in Ireland and Colombia; has sales and marketing offices in Great Britain, Singapore and China; and sales representation in Japan and Taiwan.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Adhesives Research
American Association for Clinical Chemistry
Hydrophilic adhesive technologies reduce the surface tension of fluids, such as water, urine, or blood to allow for rapid flow from the inlet area to a remote reagent site within in vitro diagnostic (IVD) and microfluidic devices. Available as pressure-sensitive adhesives (PSAs), heat-seals, and coatings, the technology is compatible with sensitive chemistries, demonstrates strong bonding to low-surface energy plastics, provides tailorable hydrophilic properties to regulate capillary fill time, and can be customized by modifying thickness, choice of substrate, and release liner.
“Hydrophilic technology continues to be used in a variety of medical devices, including blood glucose and blood coagulation point-of-care, in-house, and environmental test kits,” said Herb Hand, a senior scientist with over 24 years pioneering research on hydrophilic adhesives and coatings at AR, who will lead the discussion. “The future of hydrophilic tapes includes components in molecular diagnostic devices and devices for the discovery of infectious diseases.”
AR leverages core competencies in chemical synthesis formulation and coating technologies to provide a gamut of custom tailored products for diverse applications around the world in the construction, industrial, electronics, automotive, medical, and pharmaceutical industries. AR also operates manufacturing facilities in Ireland and Colombia; has sales and marketing offices in Great Britain, Singapore and China; and sales representation in Japan and Taiwan.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Adhesives Research
American Association for Clinical Chemistry
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Thyroid Test
Anti-Thyroid EIA Test
All-in-One Molecular System
AIO M160
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
- New Tubes Designed for Medium Sample Volumes
- Multi Sample Osmometer Improves Testing Efficiency
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Cloud-Based Connectivity Platform Advances Decentralized Healthcare
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
New Machine-Learning Equation Improves LDL Cholesterol Assessment
Accurate assessment of low-density lipoprotein (LDL) cholesterol is central to cardiovascular risk management, yet calculation methods can underestimate values in some patients. Laboratories widely use... Read more
Blood Biomarker May Signal Cognitive Decline Risk a Decade Before Symptoms
Accurately identifying which cognitively healthy older adults will later develop impairment due to Alzheimer’s disease remains difficult, as brain scans and genetic testing provide only part of the risk picture.... Read more
Molecular Diagnostics
view channel
New Biomarker Helps Guide Combination Therapy for Treatment-Resistant Breast Cancer
Chemotherapy resistance hampers treatment of triple-negative breast cancer (TNBC), particularly in tumors with TP53 mutations. Identifying biomarkers that signal resistance while pointing to actionable... Read more
Blood-Based Gene Expression Test Detects Early Pancreatic Cancer
Pancreatic cancer remains difficult to detect at a curable stage and is associated with poor survival outcomes. In Japan, the five-year relative survival rate is 8.5%, while early-stage disease accounts... Read more
Hematology
view channel
New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more
AI Decision Support System Guides Treatment Selection for Complex Blood Cancers
Treatment selection for hematologic malignancies often requires clinicians to synthesize clinical histories, genomic alterations, prior therapies, and rapidly evolving drug options. These complex decisions... Read more
Immunology
view channel
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read more
Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis
Accurately distinguishing sensitization from clinically relevant food allergy remains a challenge for laboratories, as routine blood tests detect allergen-specific immunoglobulin E (IgE) but not its capacity... Read more
Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19
Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more
Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms
Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read moreMicrobiology
view channel
Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
U.S. health authorities have reported a rapid increase in cyclosporiasis since May 2026, with more than 1,600 confirmed infections and thousands of additional suspected cases under investigation.... Read more
Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
Bloodstream infections require rapid identification of causative pathogens and resistance mechanisms to guide effective therapy. Delays in profiling gram-negative organisms, which are frequently associated... Read more
Pathology
view channel
AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity
Myelodysplastic neoplasms, a group of blood cancers that primarily affect older adults, are challenging to stage and monitor, often requiring repeated bone marrow biopsies that can yield uncertain interpretations.... Read more
Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue
Mapping the spatial distribution of disease-relevant molecules within tissue remains a diagnostic challenge, particularly before alterations are visible by conventional microscopy. In Fabry disease, a... Read more
Technology
view channel
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read more
Industry
view channel
Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition
Leica Biosystems, an operating company of Danaher, has entered into a definitive agreement to acquire privately held StatLab Medical Products from Linden Capital Partners and Audax Private Equity.... Read more
